Dependence on methamphetamine. Mental and behavioural disorders due to use psychoactive substances
Conditions
Interventions
Intervention 1: case group:oral use of caffeine, 50 - 400 mg, 1 to 4 times per day for 3 months. Intervention 2: placebo ,1 to 4 times per day for 3 months, oral use.
Treatment - Drugs
Placebo
case group:oral use of caffeine, 50 - 400 mg, 1 to 4 times per day for 3 months
placebo ,1 to 4 times per day for 3 months, oral use
Sponsors
Baqiyatallah University of Medical Sciences
Shahid Beheshti University of Medical Sciences and Health Services
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Methamphetamine Dependency according to DSM criteria; consent and commitment for participation in study; No history of Mental illness and use of psychiatric drags. Exclusion criteria: sensitivity to stimulants history of seizure or head trauma suffering from Mental illness or prior neurologic disease Hypertension or cardio vascular disease.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Craving. Timepoint: every week. Method of measurement: vsa.;Relapse rate. Timepoint: weekly. Method of measurement: urine test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Depression. Timepoint: Beginning and end of the study. Method of measurement: Beck Depression Inventory.;Anxiety. Timepoint: Beginning and end of the study. Method of measurement: Depression Anxiety Stress Scales.;Mental Health. Timepoint: Beginning and end of the study. Method of measurement: GHQ.;Quality of life. Timepoint: Beginning and end of the study. Method of measurement: WHO. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Jamal Shams
Baqiyatallah University of Medical Sciences
Outcome results
None listed